fda warning letters glp-1 compounding september 26 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers 🚨 FDA Moves to Permanently

Tell your healthcare provider if you have changes in vision during treatment with Semaglutide

Are we ready to update the guidelines, or do we need more long-term reproductive data?" #PCOS #GLP1 #MedicalAffairs #ReproductiveMedicine #MetabolicHealth #Semaglutide #WomensHealth #EvidenceBasedMedicine To view or add a comment, sign in Are we focusing on the wrong cholesterol markers

Ipamorelin is preferred for clean, selective GH pulse studies with minimal hormonal confounding

Cowie CC, Casagrande SS, Menke A (2018) Diabetes in America

In between the two extremes of science done purely for creating knowledge and science done for the sake of making useful things, there seems to be another way, a balance between discovery and invention

This new class of drugs, called glucagon-like peptide (GLP-1) receptor agonists, has proven remarkably effective at promoting weight loss and other health outcomes